Dr Sarah Maloney
People_

Dr Sarah Maloney

Clinical Senior Lecturer
Sydney Medical School
Northern Clinical School
Faculty of Medicine and Health

Publications

Journals

  • Maloney, S., Pavlakis, N., Itchins, M., Arena, J., Mittal, A., Hudson, A., Colvin, E., Sahni, S., Diakos, C., Chan, D., Gill, A., Samra, J., Clarke, S. (2023). The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer. Journal of Clinical Medicine, 12(5). [More Information]
  • Sahni, S., Pandya, A., Hadden, W., Nahm, C., Maloney, S., Cook, V., Toft, J., Wilkinson-White, L., Gill, A., Samra, J., Mittal, A., et al (2021). A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma. International Journal of Cancer, 148(6), 1508-1518. [More Information]
  • Maloney, S., Itchins, M., Arena, J., Sahni, S., Howell, V., Hayes, S., Gill, A., Clarke, S., Samra, J., Mittal, A., Pavlakis, N. (2021). Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. Journal of Clinical Medicine, 10(12), 2700. [More Information]

2023

  • Maloney, S., Pavlakis, N., Itchins, M., Arena, J., Mittal, A., Hudson, A., Colvin, E., Sahni, S., Diakos, C., Chan, D., Gill, A., Samra, J., Clarke, S. (2023). The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer. Journal of Clinical Medicine, 12(5). [More Information]

2021

  • Sahni, S., Pandya, A., Hadden, W., Nahm, C., Maloney, S., Cook, V., Toft, J., Wilkinson-White, L., Gill, A., Samra, J., Mittal, A., et al (2021). A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma. International Journal of Cancer, 148(6), 1508-1518. [More Information]
  • Maloney, S., Itchins, M., Arena, J., Sahni, S., Howell, V., Hayes, S., Gill, A., Clarke, S., Samra, J., Mittal, A., Pavlakis, N. (2021). Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. Journal of Clinical Medicine, 10(12), 2700. [More Information]
  • Wijetunga, A., Chua, T., Nahm, C., Pavlakis, N., Clarke, S., Chan, D., Diakos, C., Maloney, S., Ashrafi-Zadeh, A., Kneebone, A., Gill, A., Mittal, A., Samra, J., et al (2021). Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy: Survival in advanced pancreatic cancer. European Journal of Surgical Oncology, 47(10), 2543-2550. [More Information]

2020

  • Sahni, S., Nahm, C., Krisp, C., Molloy, M., Mehta, S., Maloney, S., Itchins, M., Pavlakis, N., Clarke, S., Chan, D., Gill, A., Howell, V., Samra, J., Mittal, A. (2020). Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy. Frontiers in Oncology, 10, 1-10. [More Information]
  • Sahni, S., Krisp, C., Molloy, M., Nahm, C., Maloney, S., Gillson, J., Gill, A., Samra, J., Mittal, A. (2020). PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression. Biochimica et Biophysica Acta - General Subjects, 1864 (11), 1-6. [More Information]